NeoGenomics, Inc. To Present At Noble Financial Group's 2006 ONTRACK Small Cap Conference And Micro Cap Symposium
FT. MYERS, Fla., Sept. 21 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetic diagnostic testing services, announced today that President and Chief Scientific Officer Bob Gasparini will present at the 2006 ONTRACK Small Cap Conference and Micro Cap Symposium sponsored by Noble Financial Group on Thursday, September 28 beginning at 10:15 a.m. in Charlotte, N.C.
Noble Financial will showcase close to 100 small and microcap public companies at the event. Gasparini and other senior executives of attending companies will make presentations to portfolio managers and analysts on their business strategy and outlook. One-on-one meetings with interested parties will also be arranged during the three-day conference.
A webcast of the presentation can be accessed at http://hosted.mediasite.com/hosted/viewer/?peid=43082912-317b-425e-aa71- 760f3e544aca. (Due to length of URL, please cut and paste into browser.) A PowerPoint presentation and a link to the webcast can also be accessed at http://hawkassociates.com/ngnmmore.aspx at the time of the conference. The webcast will be available for three months.
About Noble Financial Group
Noble Financial is a privately held, full-service capital markets firm driven by what is often overlooked by others with a focus on converting market inefficiencies into profit opportunities. Noble Financial supports emerging growth companies through strategic advice, investment banking, market making, sales and trading, comprehensive equity research, and the development of institutional support. For more information on the 2006 ONTRACK Noble Small Cap and Micro Cap Conference, visit http://www.ontrack06.com.
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The Company analyzes chromosomes, genes and DNA for the presence of cancerous disease states through its cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry and molecular genetic testing services. NeoGenomics with labs in Nashville, TN and Ft. Myers, FL is headquartered in Fort Myers and services the needs of oncologists, pathologists, urologists, hospitals and other reference laboratories throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.
An investment profile about NeoGenomics may be found online at http://www.hawkassociates.com/ngnmprofile.aspx. Interested parties can also access an in-depth equity research report, from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm.
An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com. For investor relations questions regarding NeoGenomics, contact Frank Hawkins or Julie Marshall, Hawk Associates, at (305) 451-1888, e-mail: info@hawkassociates.com.
NeoGenomics, Inc.CONTACT: Investor Relations, Steven C. Jones, Director of InvestorRelations of NeoGenomics, Inc., +1-239-598-0964, or sjones@neogenomics.org;or Frank N. Hawkins or Julie Marshall of Hawk Associates, Inc.,+1-305-451-1888, or info@hawkassociates.com, for NeoGenomics, Inc.